You might think that making AI faster means giving it more memory. More storage, bigger chips, problem solved. But that intuition is wrong — and the real answer

Not long ago, building a production-grade AI agent system meant months of engineering work before a single line of business logic got written. You needed distri

A few years ago, a startup was charging people tens of thousands of dollars to infuse them with plasma from young donors. The FDA eventually issued a statement:

In 2026, NMN entered its first clinical trial for autoimmune disease and appeared in Nature Medicine. Combined with new evidence on T cell senescence reversal and exercise-driven SIRT1 activation, three studies map NAD+ as an immune calibrator.

There's a contradiction sitting at the center of anti-aging biology that doesn't get explained enough: some researchers are working hard to increase autophagy